HK17096A - Pertussis toxin mutants bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines - Google Patents

Pertussis toxin mutants bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

Info

Publication number
HK17096A
HK17096A HK17096A HK17096A HK17096A HK 17096 A HK17096 A HK 17096A HK 17096 A HK17096 A HK 17096A HK 17096 A HK17096 A HK 17096A HK 17096 A HK17096 A HK 17096A
Authority
HK
Hong Kong
Prior art keywords
mutants
bordetella strains
pertussis toxin
development
producing
Prior art date
Application number
HK17096A
Other languages
English (en)
Inventor
Marigrazia Pizza
Antonello Covacci
Rino Rappuoli
Luciano Nencioni
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26327122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK17096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IT8920341A external-priority patent/IT1230139B/it
Priority claimed from IT01928690A external-priority patent/IT1238007B/it
Application filed by Sclavo Spa filed Critical Sclavo Spa
Publication of HK17096A publication Critical patent/HK17096A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK17096A 1989-04-28 1996-02-01 Pertussis toxin mutants bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines HK17096A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8920341A IT1230139B (it) 1989-04-28 1989-04-28 Ceppi di bordetella utili come vaccini antipertosse
IT01928690A IT1238007B (it) 1990-02-07 1990-02-07 Mutanti della tossina della pertosse, ceppi di bordetella capaci di produrre detti mutanti e loro impiego per lo sviluppo di vaccini antipertosse

Publications (1)

Publication Number Publication Date
HK17096A true HK17096A (en) 1996-02-09

Family

ID=26327122

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17096A HK17096A (en) 1989-04-28 1996-02-01 Pertussis toxin mutants bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

Country Status (10)

Country Link
US (2) US7427404B1 (fr)
EP (1) EP0396964B1 (fr)
JP (2) JP2655583B2 (fr)
AT (1) ATE127347T1 (fr)
CA (1) CA2015677C (fr)
DE (1) DE69022106T2 (fr)
DK (1) DK0396964T3 (fr)
ES (1) ES2078258T3 (fr)
GR (1) GR3018285T3 (fr)
HK (1) HK17096A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine
DK0396964T3 (da) * 1989-04-28 1995-10-30 Sclavo Spa Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
DE4113385A1 (de) * 1991-04-24 1992-10-29 Biotechnolog Forschung Gmbh Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
GB9513371D0 (en) 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
AU7788194A (en) * 1993-10-05 1995-05-01 Medeva Holdings B.V. Vaccine compositions
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
AU2001271495A1 (en) * 2000-06-26 2002-01-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A high yield pertussis vaccine production strain and method for making same
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
BRPI0402630B8 (pt) * 2004-07-05 2021-05-25 Fund Butantan processo de obtenção de vacina pertussis celular menos reatogênica
CA2759681C (fr) * 2009-04-24 2019-09-17 Kathleen M. Tatti Detection selective d'especes de bordetella
US20100317593A1 (en) * 2009-06-12 2010-12-16 Astrazeneca Ab 2,3-dihydro-1h-indene compounds
KR20130072201A (ko) 2010-03-30 2013-07-01 피페넥스 인크. 재조합 독소 단백질의 고수준 발현
ES2642138T3 (es) * 2011-12-21 2017-11-15 Bionet-Asia Co. Ltd Cepas de Bordetella pertussis modificadas
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CA2886938A1 (fr) 2012-10-12 2014-04-17 Glaxosmithkline Biologicals S.A. Antigenes de pertussis acellulaires non reticules pour leur utilisation dans des vaccins combines
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
AU2014304545A1 (en) 2013-08-05 2016-02-25 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
KR20170137867A (ko) 2015-04-16 2017-12-13 인벤트프라이즈 엘엘씨 보르데텔라 퍼투시스 면역원성 백신 조성물
AR117191A1 (es) 2018-11-06 2021-07-21 Glaxosmithkline Biologicals Sa Composiciones inmunogénicas
EP3799884A1 (fr) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Compositions immunogènes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
CA1340373C (fr) * 1986-01-28 1999-02-02 Rino Rappuoli Clonage et sequencage du fragment d'adn qui code les cinq sous-unites de l'anatoxine coquelucheuse, plasmide hybride contenant le fragment d'adnet microorganismes transformes par le plasmide hybride et capables d'exprimer toutes les sous-unites de l'anatoxine coquelucheuse ou certaines d'entre elles
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
KR0168039B1 (ko) * 1987-09-04 1999-01-15 로버트 디. 웨스트 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
US6713072B1 (en) * 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
US5221618A (en) 1987-11-24 1993-06-22 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
IT1223529B (it) * 1987-12-18 1990-09-19 Sclavo Spa Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
DK0396964T3 (da) * 1989-04-28 1995-10-30 Sclavo Spa Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner

Also Published As

Publication number Publication date
US7666436B1 (en) 2010-02-23
ES2078258T3 (es) 1995-12-16
JP2852025B2 (ja) 1999-01-27
CA2015677C (fr) 2005-06-21
DE69022106T2 (de) 1996-02-15
CA2015677A1 (fr) 1990-10-28
ATE127347T1 (de) 1995-09-15
US7427404B1 (en) 2008-09-23
GR3018285T3 (en) 1996-03-31
JP2655583B2 (ja) 1997-09-24
DK0396964T3 (da) 1995-10-30
JPH03169825A (ja) 1991-07-23
JPH09163978A (ja) 1997-06-24
EP0396964B1 (fr) 1995-09-06
EP0396964A1 (fr) 1990-11-14
DE69022106D1 (de) 1995-10-12

Similar Documents

Publication Publication Date Title
GR3018285T3 (en) Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines.
ATE183214T1 (de) Tenside zur polyurethanschaumstoffherstellung
GB9626484D0 (en) Helicobacter pylori antigenic protein preparation and immunoassays
ES2180758T3 (es) Vacunas de pertussis acelulares y metodos de preparacion de las mismas.
HK192995A (en) Bordetella pertussis toxin with altered toxicity
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
AU5533490A (en) Synthetic (pseudomonas) (aeruginosa) pilin peptide and related vaccines and diagnostics
IL82769A0 (en) Device for treating hypoestrogenic women
CA2075711A1 (fr) Vaccin et methode de fabrication
DE242301T1 (de) Reinigungsverfahren der proteischen antigene von bordetella-bakterien zur gewinnung eines azellularen vakzins.
CA2004206A1 (fr) Methodes de preparation de l'anatoxine coquelucheuse
EP0320866A3 (fr) Epitope protecteur immunodominant, compris dans la sous-unité S1 de la toxine de pertussis
FR2393565A1 (fr) Procede et dispositif de fixation amovible de protheses, notamment de protheses dentaires
CA2092420A1 (fr) Vaccin anti-Bortedella Pertussis
GB9502899D0 (en) Novel antigen
MX9708480A (es) Vacunas acelulares de pertussis y metodos de preparacion de las mismas.
EP0290246A3 (fr) Vaccin pour provoquer une réponse immunogène des cellules-T protectrice contre le virus de la rage
IT1230139B (it) Ceppi di bordetella utili come vaccini antipertosse
IT1238007B (it) Mutanti della tossina della pertosse, ceppi di bordetella capaci di produrre detti mutanti e loro impiego per lo sviluppo di vaccini antipertosse

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100424